PRISMAP @ EANM 2025
Below is an overview of PRISMAP members’ participation at the 2025 EANM conference, including poster sessions, presentations, and details of the special PRISMAP Session on Sunday, 5 October.
Join our special session: a unique opportunity to learn about PRISMAP’s journey, user experiences, and translational applications of its radionuclides in nuclear medicine research and therapy.
5 October 14:00—14:30 Room 121
- Thierry Stora – The PRISMAP project Past & Future (10 min)
- Eleni Gourni – A PRISMAP user’s experience (5 min)
- Clemens Decristoforo – PRISMAP radionuclides – translational activities (5 min)
5 October 8:32—8:36 Poster presentation
Dr. Naveen Kumar — Preclinical Evaluation of a 47Sc-labeled Gastrin Releasing Peptide-based Radioantagonist for the Targeted Management of Breast Cancer
5 October 9:16—9:20 Poster presentation
Melissa Crabbé — The absorbed dose-response relationship of the Auger electrons from La-135
7 October 8:30—8:40 Poster presentation
Dr. Naveen Kumar — Targeted Radionuclide Therapy of Prostate Cancer using a 177Lu- and 47Sc-labeled Gastrin-Releasing Peptide Receptor Antagonist. Evaluation as Monotherapy and in Combination with Everolimus
Poster presentation
Kristof Baete — Nuclear medicine equipment standardisation for clinical translation: a case study with Tb-161
Poster presentation
D. Pawlak and R. Mikołajczak — Small-scall production of 161Tb